skip to main content

Listen

Read

Watch

Schedules

Programs

Events

Give

Account

Donation Heart Ribbon

Should Patients Have A Voice In FDA Drug Approvals?

January 31, 2011 1:31 p.m.

People suffering from rare or chronic diseases often have to wait years for new drugs to get through the complicated regulatory process in the US. But, putting prescription drugs on the market too soon can put patients at risk. On our monthly segment on ethics in science and technology, we'll talk about the ethics of giving patients more of a voice in the regulatory decision-making process.

Related Story: Should Patients Have A Voice In FDA Drug Approvals?